Latest Breaking News On - Therapeuticsavenue therapeutics inc - Page 1 : comparemela.com

Avenue Therapeutics (ATXI) Reaches Agreement with the FDA on the Study Design and Analysis Approach of the Phase 3 Safety Study for IV Tramadol

Avenue Therapeutics (ATXI) Reaches Agreement with the FDA on the Study Design and Analysis Approach of the Phase 3 Safety Study for IV Tramadol
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAlexandra macleanAvenue therapeutics incFortress biotech incJaclyn jaffeavenue therapeutics incTherapeuticsavenue therapeutics incDrug administrationAvenue therapeuticsChief executive officerAvenue therapeuticsavenue therapeuticsFortress biotechLooking statementsthisPrivate securities litigation reform actJaclyn jaffeavenue therapeutics

Avenue Therapeutics (ATXI) will participate in a Type C meeting with the FDA on March 9

Avenue Therapeutics (ATXI) will participate in a Type C meeting with the FDA on March 9
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBay harbor islandsLindsay rosenwaldAlexandra macleanJay kranzlerDavid jinAvenue therapeutics incTherapeutics incSecurities exchangeFortress biotech incCompany bylawsTherapeuticsavenue therapeutics incTypec meeting requestChief executive officerAnnual meetingSecurities exchange act

Avenue Therapeutics (ATXI) Enters into License Agreement with AnnJi Pharmaceutical to Develop and Commercialize AJ201

Avenue Therapeutics (ATXI) Enters into License Agreement with AnnJi Pharmaceutical to Develop and Commercialize AJ201
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomGreat britainLindsaya rosenwaldAlexandra macleanDrug administrationAvenue therapeutics incTherapeutics incEuropean unionTherapeuticsavenue therapeutics incAnnji pharmaceutical co ltdFortress biotech incWall streetChief executive officerOrphan drug designationAvenue therapeuticsavenue therapeutics

Avenue Therapeutics Announces Closing of $12 Million Underwritten Public Offering

Avenue Therapeutics Announces Closing of $12 Million Underwritten Public Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesBaergic bioKaufman canolesExchange commissionJaclyn jaffeavenue therapeutics incAvenue therapeutics incTherapeuticsavenue therapeutics incInvagen pharmaceuticals incAegis capital corpAvenue therapeuticsavenue therapeuticsLooking statements thisPrivate securities litigation reform actJaclyn jaffeavenue therapeutics